American Health Packaging is the latest company to recall a ranitidine product after discovering it produces a possible carcinogen.
The company is recalling eight lots of its 150 mg ranitidine syrup to the consumer level after it found trace amounts of N-nitrosodimethylamine in the heartburn medication. It is the same carcinogen that prompted recalls from several other drugmakers.
The syrup was manufactured by Lannett Company and repackaged by American Health Packaging. It was distributed nationwide to wholesalers for use in hospitals.
American Health Packaging has not received any reports of adverse events related to the recall. The company told distributors to immediately discontinue distribution of the affected lots and to notify subaccounts.
Read the full news release here.